Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable 3-75 (IGHV3-75) is a germline gene segment that encodes the variable (V) domain of the heavy chain in immunoglobulins (antibodies)[1][2]. This variable domain, through V(D)J recombination and subsequent somatic hypermutation, contributes to the enormous diversity of antibodies produced by B cells in the adaptive immune system[1][2]. Each antibody’s antigen-binding site is formed by a unique combination of variable domains from both the heavy and light chains, enabling specific recognition of a vast array of antigens[1]. IGHV3-75 is one out of many similar variable genes in the human genome and is not a protein or molecular target for therapy on its own. The designation VH3 refers to its membership in the VH3 subfamily of immunoglobulin heavy variable genes, which all encode slightly different variable region sequences, further increasing antibody repertoire diversity[2]. These gene segments are located in the immunoglobulin heavy chain locus on chromosome 14 in humans. Summary: IGHV3-75 is a genetic segment contributing to antibody diversity, not a standalone therapeutic target, receptor, or biomarker. It is correctly labeled as a germline immunoglobulin gene variable region segment and used in antibody gene recombination, but there is no evidence for a direct therapeutic or biological targeting relevance for this gene itself[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable 3-75 (IGHV3-75).